PharmaVOICE - 
January 2017
Purchase Issue

In Every Issue
Letter from the Editor
Welcome to 2017 From funding to policy changes, 2017 according [...]
By

Taren Grom, Editor

Upfront
Lilly to Expand  Global Access to Healthcare Eli Lilly and [...]
By

PharmaVOICE Staff

A Conversation with Dr. Cameron Durrant
In an exclusive interview with PharmaVOICE’s Editor Taren Grom, Cameron [...]
By

Cameron Durrent, M.D., CEP amd Chairman, KaloBios

Innovator’s Corner
A New Way to Treat Severe Asthma Dr. Bing Yao, [...]
By

Dr. Bing Yao, Respiratory, Inflammation & Autoimmunity Head, MedImmune

HealthTech
AI and mHealth Tech: Instruments to Better Healthcare Computers can [...]
By

PharmaVOICE Staff

Last Word
Rising Pharma Opportunities in China Rick Pauls, President and CEO [...]
By

Rick Pauls, President and CEO, DiaMedica

On The Cover

Venture Capital Funding
According  to the MoneyTree Report from PwC, the life-sciences industry continues to be the second most invested destination after software, in terms of dollars. Life-Sciences’ VC Investment The life-sciences’ record-high investment spree of 2015 came to an end in Q4 with the lowest quarter of investments during the year, signaling a slow down in the [...]
By

PharmaVOICE Staff

Features

Don’t Mistake Copy for Content Marketing
More than half — 58% — of the pharma/biotech industry is spending more than million in content development every year, but much of that content is not connected to a solid objective, which means money and time are being wasted. In a recent Accenture study, only 11% of pharma/biotech marketers reported they have a [...]
By

Robin Robinson

Organs On Chips
One day, precision medicine will take into account the genes, environment, and lifestyle of each person. Through the use of an emerging technology that melds engineering, biology, and IT, researchers are able to see what hasn’t been possible before: the inner workings of human biology and disease. This new technology is just starting to be [...]
By

Denise Myshko

Global Expedited Review
Following the implementation of the Food and Drug Administration’s  Breakthrough Therapy Designation in 2012, both the European Union’s and Japan’s regulatory agencies began the process of determining how to provide an expedited review for therapies for serious diseases with unmet needs. The results of these efforts included the European Medicines Agency’s launch of the PRIME [...]
By

Denise Myshko

Disease State: HIV Update
Since the beginning of the HIV epidemic, almost 70 million people worldwide have been infected with the virus that causes AIDS. It is estimated that 36.7 million people are currently living with HIV globally. Tremendous gains have been made in treating these patients, helping them to live longer, healthier lives. Antiretroviral drugs have been credited [...]
By

Denise Myshko

Focus on Rare Diseases
Rare diseases have been a focus of drug development for decades, and since the 1980s, there have been financial, legal, and legislative incentives, such as the Orphan Drug Act, that are drawing companies of all sizes to enter the market. Rafal Kokolus, senior engagement manager, inVentiv Health Consulting, believes the rare disease market has passed [...]
By

PharmaVOICE Staff

SHOWCASE FEATURE: Social Media
Social Media Trends What’s hot, what’s not, and the analytics driving it all. For the first time, digital and social media ad spending — .09 billion — surpassed that of TV — .29 billion, according to a recent study from eMarketer. This shift may have marketers everywhere revisiting their strategies, leading to big changes in [...]
By

PharmaVOICE Staff

Social Media Is Pharma’s Key To Reaching Millennials
Millennials? Hmmph. “I’m sick of hearing about them. They’re not driving my business, and I couldn’t care less about them.” If you fall into this camp, you’re not reading the tea leaves. Today, the average age of a millennial is 26. They are the largest generation in the United States, at 75.4 million people,1 and [...]
By

Joe Youssef, Engagement Strategy, Digital, Ogilvy CommonHealth, part of Ogilvy CommonHealth Worldwide

Ease Your Way Into Social
As the generation marketers have labeled “millennials” mature into their role as heads of family and healthcare consumers, how can modern pharmaceutical brands begin to build a relationship with them? For a generation that has come of age as digital and social media natives, how do we engage with millennials in their most comfortable zone? [...]
By

Winnie Tan, Associate Social Media Strategist, Digital, Ogilvy CommonHealth, part of Ogilvy CommonHealth Worldwide

Transcending Traditional Social Media: From Awareness to Uncovering Actionable Insights
It goes without saying that social media is one of the most widely used forms of communication today.  Pharmaceutical companies are trying to “crack the code” and understand how to effectively use this channel to achieve organizational initiatives while complying with rigorous industry regulations. Progressive companies have navigated this challenging environment, breaking new ground and [...]
By

Dr. Theodore Search, Pharm.D., CEO and Founder, Skipta

FEEDBACK